Significant Ownership of Bradford T. Whitmore
- Large-stake filing summary
-
- Recent SEC Schedule 13D/G filings for Bradford T. Whitmore focus on large-stake beneficial ownership disclosures and amendments.
- Use this view to spot new large holders, amended positions, and activist-style ownership evidence.
- Manager signature
- Bradford T. Whitmore - Bradford T. Whitmore
- Manager location
- Skokie, IL
Large-stake snapshot
1 signal
Manager
Names, identifiers, and filing context for this profile.
2 identity fields
Follow Filing Activity
Follow Bradford T. Whitmore with Pro and return when a new Schedule 13D/G filing changes the record on this page.
Pro alert delivery is coming soon and remains tied to source-backed filing changes rather than inferred market advice.
CIK context first
Continue from Bradford T. Whitmore
Significant Ownership of Bradford T. Whitmore
| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| SLSN | SOLESENCE, INC. | Common Stock, par value $.01 | 71% | $194,324,540 | 49,826,805 | WHITMORE BRADFORD T | 29 May 2025 | ||
| ULBI | ULTRALIFE CORP | Common Stock, $.10 par value per share | 40% | $37,751,754 | 6,599,957 | WHITMORE BRADFORD T | 12 Mar 2026 | ||
| CLSD | Clearside Biomedical, Inc. | Common Stock, $.001 Par Value | 8.6% | $5,479,749 | 6,523,511 | WHITMORE BRADFORD T | 31 Dec 2024 |
Schedules 13D/G Reported by Bradford T. Whitmore:
| Sym | Target | Class | Ownership | Change | Current shares | Change | Value | Reporting name | Form | Report period | Filing date |
|---|
Schedule rows are parsed from SEC 13D/G filings. Open the linked filing or target page to verify the reported ownership and shares.